Indoximod-based chemo-immunotherapy for pediatric brain tumors
A first-in-children phase I trial
- Johnson, Theodore S
- MacDonald, Tobey J
- Pacholczyk, Rafal
- Aguilera, Dolly
- Al-Basheer, Ahmad
- Bajaj, Manish
- Bandopadhayay, Pratiti
- Berrong, Zuzana
- Bouffet, Eric
- Castellino, Robert C
- Dorris, Kathleen
- Eaton, Bree R
- Esiashvili, Natia
- Fangusaro, Jason R
- Foreman, Nicholas
- Fridlyand, Diana
- Giller, Cole
- Heger, Ian M
- Huang, Chenbin
- Kadom, Nadja
- Kennedy, Eugene P
- Manoharan, Neevika
- Martin, William
- McDonough, Colleen
- Parker, Rebecca S
- Ramaswamy, Vijay
- Ring, Eric
- Rojiani, Amyn
- Sadek, Ramses F
- Satpathy, Sarthak
- Schniederjan, Matthew
- Smith, Amy
- Smith, Christopher
- Thomas, Beena E
- Vaizer, Rachel
- Yeo, Kee Kiat
- Bhasin, Manoj K
- Munn, David H
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Pediatrics, Augusta University, Augusta, Georgia, USA
Aflac Cancer & Blood Disorders Center at Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, Massachusetts, USA
Aflac Cancer & Blood Disorders Center at Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Radiation Oncology, Augusta University, Augusta, Georgia, USA
Department of Radiology, Augusta University, Augusta, Georgia, USA
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada
Aflac Cancer & Blood Disorders Center at Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Department of Pediatrics, Children’s Hospital Colorado, Aurora, Colorado, USA
Department of Radiation Oncology and Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Radiation Oncology and Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Aflac Cancer & Blood Disorders Center at Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Department of Pediatrics, Children’s Hospital Colorado, Aurora, Colorado, USA
Department of Pediatrics, Augusta University, Augusta, Georgia, USA
Department of Neurosurgery, Augusta University, Augusta, Georgia, USA
Department of Neurosurgery, Augusta University, Augusta, Georgia, USA
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Department of Biomedical Informatics, Emory University, Atlanta, Georgia, USA
Department of Radiology and Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Lumos Pharma, Inc. (formerly NewLink Genetics Corporation), Austin, Texas, USA
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, Massachusetts, USA
Department of Radiation Oncology, Augusta University, Augusta, Georgia, USA
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Pediatrics, Augusta University, Augusta, Georgia, USA
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Pediatrics, Augusta University, Augusta, Georgia, USA
Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Pediatrics, Augusta University, Augusta, Georgia, USA
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Pathology, Augusta University, Augusta, Georgia, USA
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Population Health Sciences, Augusta University, Augusta, Georgia, USA
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Department of Biomedical Informatics, Emory University, Atlanta, Georgia, USA
Children’s Healthcare of Atlanta and Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA
Department of Pediatrics, Arnold Palmer Hospital for Children, Orlando, Florida, USA
Lumos Pharma, Inc. (formerly NewLink Genetics Corporation), Austin, Texas, USA
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Department of Pediatrics, Augusta University, Augusta, Georgia, USA
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, Massachusetts, USA
Aflac Cancer & Blood Disorders Center at Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Department of Biomedical Informatics, Emory University, Atlanta, Georgia, USA
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
Department of Pediatrics, Augusta University, Augusta, Georgia, USA
Corresponding Author: Theodore S. Johnson, MD, PhD, Georgia Cancer Center, Augusta University, 1120 Fifteenth St., CN-4141A, Augusta, GA, USA ([email protected]).
Manish Bajaj Present address: Children’s Healthcare of Atlanta and Department of Radiology, Emory University, Atlanta, Georgia, USA;
Ian M. Heger Present address: Department of Surgery (Neurosurgery), Texas Christian University School of Medicine, Fort Worth, TX Medical City Children’s Hospital, Dallas, Texas, USA;
Neevika Manoharan Present address: Kids Cancer Centre, Sydney Children’s Hospital, Randwick, Australia;
Rebecca S. Parker Present address: Cancer and Blood Diseases Institute, Children’s Hospital Los Angeles, Los Angeles, California, USA;
Amyn Rojiani Present address: Department of Pathology, Penn State Health/College of Medicine, Hershey, Pennsylvania, USA;
Rachel Vaizer Present address: Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA
Revised October 13, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]
